CEO & Co-founder
Neurosalience
Neurosalience develops a tool for the early detection of dementia utilizing structural MRI and CT data. This technology employs interpretable machine learning algorithms to assess brain aging risk, even with low-resolution scans. Early risk assessment enables timely lifestyle changes, potentially slowing disease progression and reducing long-term patient care costs.
- Artificial Intelligence
- Digital Health
- Healthcare Technology
- Software Only
Updated 6 months ago
Funding
Raised to date
$310KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Neurosalience develops a tool for the early detection of dementia utilizing structural MRI and CT data. This technology employs interpretable machine learning algorithms to assess brain aging risk, even with low-resolution scans. Early risk assessment enables timely lifestyle changes, potentially slowing disease progression and reducing long-term patient care costs.